Two Sigma Securities, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.11 - $5.46 $9,296 - $461,468	84,518 New	84,518 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.21 - $0.53 $8,037 - $20,284	38,273 New	38,273 $10,000
Q1 2022 May 16, 2022	SELL	$0.32 - $0.67 $14,719 - $30,817	-45,997 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $27,598 - $51,056	45,997 New	45,997 $28,000
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.82 $23,572 - $42,476	-23,339 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.39 - $2.21 $32,441 - $51,579	23,339 New	23,339 $43,000
Q1 2018 May 15, 2018	SELL	$5.6 - $9.25 $63,117 - $104,256	-11,271 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $74,388 - $87,688	11,271	11,271 $80,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.14B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.